Technology | December 09, 2014

Volpara Solutions Launches VolparaAnalytics 1.2 at RSNA

Next generation quality assurance tool delivers expanded breast imaging metrics to provide critical insight for breast imaging workflow

Mammography systems, women's health, RSNA 2014, Volpara, breast density

Image courtesy of Volpara Solutions

December 9, 2014 — Volpara Solutions launched VolparaAnalytics version 1.2 at RSNA 2014. Volpara Solutions showcased the latest version of VolparaAnalytics and the rest of its suite of quantitative breast imaging tools, including VolparaDensity and VolparaDoseRT, which enable personalized measurements of volumetric density, patient-specific dose, breast compression and other factors designed to provide insight for breast imaging quality and workflow.

VolparaAnalytics, a centralized dashboard that presents key mammography metrics, works by automatically collating data from digital mammography and tomosynthesis units to enable cross-comparison of patient populations, mammography systems and operator performance. VolparaAnalytics is in use supporting quality assurance at breast imaging centers around the globe by monitoring critical elements of the breast imaging process and generating key metrics to help breast imaging centers identify and address potential issues early.

The new version of VolparaAnalytics, which will be available in early 2015, features an enhanced user interface and reporting tools, and delivers expanded breast imaging metrics to users including additional quality metrics, new temporal analysis tools, additional tools to analyse patient positioning and patient-dose and time between study acquisitions.

Volpara Solutions was recently recognized with the 2014 Technology Innovation Leadership Award in Breast Imaging from Frost & Sullivan based on independent analysis of the company’s technology excellence and visionary innovation. 

“One key new feature of the latest version of VolparaAnalytics is temporal analysis reporting, which allows users to view key breast imaging metrics such as compression force, applied pressure and mean glandular dose results over time to quickly identify inconsistencies that might have developed,” said Ralph Highnam, PhD., Volpara Solutions CEO and Chief Scientist.  “By providing objective volumetric context, this provides actionable insight to help breast centers improve patient care and productivity.”

VolparaAnalytics runs on top of VolparaDensity, a software tool in use at breast imaging centers worldwide to help radiologists objectively assess density from both digital mammography and tomosynthesis images and to determine which women would benefit from additional screening.  Highly correlated to breast MR assessments, VolparaDensity is a reliable tool that automatically generates an objective measurement of volumetric breast density correlated to the ACR (American College of Radiology) breast density categories.  To date, more than 4-million women have had their breast density analyzed using VolparaDensity. VolparaDoseRT provides a standardized measurement of patient-specific dose with consistent dose results across mammography systems from different manufacturers.

For more information: www.volparasolutions.com

 

Related Content

Imago Systems Announces Collaboration With Mayo Clinic for Breast Imaging

Image courtesy of Imago Systems

News | Mammography | August 14, 2019
Image visualization company Imago Systems announced it has signed a know-how license with Mayo Clinic. The multi-year...
Artificial Intelligence Could Yield More Accurate Breast Cancer Diagnoses
News | Artificial Intelligence | August 13, 2019
University of California Los Angeles (UCLA) researchers have developed an artificial intelligence (AI) system that...
Lake Medical Imaging Selects Infinitt for Multi-site RIS/PACS
News | PACS | August 09, 2019
Infinitt North America will be implementing Infinitt RIS (radiology information system)/PACS (picture archiving and...
Volpara to Distribute Screenpoint Medical's Transpara AI Solution
News | Breast Imaging | August 02, 2019
Volpara Solutions and ScreenPoint Medical BV signed an agreement under which Volpara will sell ScreenPoint's Transpara...
Videos | Radiology Business | August 02, 2019
Association for Medical Imaging Management (AHRA) President ...
Ikonopedia Releases Automated Combined Reporting Package at AHRA
News | Mammography Reporting Software | July 26, 2019
Ikonopedia showcased its recently released Automated Combined Reporting package and its entire suite of structured...
Hologic Partners With MagView to Develop Unifi EQUIP Solution
Technology | Mammography Reporting Software | July 25, 2019
Hologic announced a partnership with mammography information solutions provider MagView to develop Unifi EQUIP, an...
Fujifilm Releases Tomosynthesis Biopsy Option for Aspire Cristalle Mammography System
Technology | Breast Biopsy Systems | July 24, 2019
Fujifilm Medical Systems U.S.A. Inc. recently expanded its breast imaging solutions with the launch of its...
IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017.

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017, and who had health records for at least one year prior to the mammogram. The algorithm was trained on 9,611 mammograms. Image courtesy of Radiology.

Feature | Artificial Intelligence | July 19, 2019 | Michal Chorev
Breast cancer is the global leading cause of cancer-related deaths in women, and the most commonly diagnosed cancer...
Paragon Biosciences Launches Qlarity Imaging to Advance FDA-cleared AI Breast Cancer Diagnosis System

Qlarity Imaging’s software is used to assist radiologists in the assessment and characterization of breast lesions. Imaging features are synthesized by an artificial intelligence algorithm into a single value, the QI score, which is analyzed relative to a database of reference abnormalities with known ground truth. Image courtesy of Business Wire.

Technology | Artificial Intelligence | July 18, 2019
Paragon Biosciences LLC announced the launch of its seventh portfolio company, Qlarity Imaging LLC, which was founded...